Language Select
Logotipo da Varian

Press Releases

Agosto 21, 2019
Varian (NYSE: VAR) today announced that Phil Febbo, MD, chief medical officer (CMO) at Illumina has been appointed to the Varian Board of Directors, effective August 16, 2019. "We are proud to... Read more
Agosto 21, 2019
Varian (NYSE: VAR) today announced it has successfully completed its asset purchase of the Boston Scientific portfolio of drug-loadable microsphere and bland embolic bead products for treating... Read more
Agosto 19, 2019
Varian (NYSE: VAR) today announced that its executive management team will be hosting an Investor Day on Friday, November 15, 2019 at The Plaza Hotel, Fifth Avenue at Central Park South, New York,... Read more
Agosto 08, 2019
This afternoon, Varian (NYSE: VAR) posted a presentation providing an overview of the recently proposed radiation oncology alternative payment model and calendar year 2020 rates by the Center for... Read more
Agosto 08, 2019
Varian (NYSE: VAR) today announced that its executive staff will be meeting with analysts and investors at the American Society for Radiation Oncology (ASTRO) Annual Meeting in Chicago on Monday,... Read more
Agosto 05, 2019
Varian (NYSE: VAR) today announced that the newly proposed tariffs by the U.S. on the remaining $300 billion of Chinese imports should have no material impact to the company. Last Thursday, the... Read more
Julho 29, 2019
Following a public competitive review process, Varian (NYSE: VAR) was selected to supply its Eclipse™ treatment planning software and ARIA® oncology information system to three radiotherapy... Read more
Julho 25, 2019
Varian (NYSE: VAR) announced that the Karolinska University Hospital Solna in Sweden is the first hospital in Scandinavia to deliver High Dose Rate (HDR) brachytherapy treatments using the new... Read more
Julho 24, 2019
Third Quarter 2019 Summary Oncology Systems gross orders grew 2% in dollars, or 4% in constant currency; Trailing twelve months gross orders grew 11% in dollars, or 13% in constant currency Total... Read more
Julho 11, 2019
Varian (NYSE: VAR) today announced it will be showcasing systems and software from its cancer care portfolio, including the IDENTIFY™ Guidance System, at the American Association of Physicists... Read more

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
mark.plungy@varian.com

Investor Relations Contact

Mike Bruff
SVP, Investor Relations
650.424.5163
investors@varian.com